SCHEMBL6777103

SCHEMBL6777103

CCOC(=O)CCC#CNC(=O)CNC(=O)c1cccc(NC(=NC#N)NC)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 1/20 0.38
ITGA5 P08648 1/20 0.38
KMT2A Q03164 4/20 0.36
MEN1 O00255 2/20 0.36
ALDH1A1 P00352 3/20 0.36
GAA P10253 1/20 0.36
SMN1; SMN2 Q16637 5/20 0.35
TSHR P16473 1/20 0.35
MAPT P10636 2/20 0.35
NR1H4 Q96RI1 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
RAB9A P51151 3/20 0.34
POLB P06746 2/20 0.34
PKM P14618 1/20 0.34
LMNA P02545 3/20 0.33
NPC1 O15118 2/20 0.33
MAPK1 P28482 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
HSD17B10 Q99714 1/20 0.33
MITF O75030 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6777356 0.89 ITGB1 (0.42) ITGB1ITGA5GAASMN1; SMN2RAB9A
SCHEMBL7339128 0.88 GRK2 (0.35) KMT2AMEN1ALDH1A1GAASMN1; SMN2
SCHEMBL7342958 0.84 KMT2A (0.41) KMT2AMEN1ALDH1A1GAASMN1; SMN2
SCHEMBL6783445 0.83 KMT2A (0.40) KMT2AMEN1ALDH1A1GAASMN1; SMN2
SCHEMBL7343782 0.82 ALDH1A1 (0.39) KMT2AMEN1ALDH1A1GAASMN1; SMN2
SCHEMBL6776736 0.80 NAMPT (0.48) KMT2AMEN1ALDH1A1TSHRMAPT
SCHEMBL6777100 0.79 ITGB3 (0.43) ITGB1ITGA5KMT2AMEN1ALDH1A1
SCHEMBL27485848 0.78 LMNA (0.48) KMT2AMEN1ALDH1A1MAPTRAB9A
SCHEMBL6777095 0.77 ITGB1 (0.43) ITGB1ITGA5KMT2AMEN1ALDH1A1
SCHEMBL27427176 0.74 ITGB1 (0.40) ITGB1ITGA5KMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0850221-B1 META-GUANIDINE, UREA, THIOUREA OR AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS SEARLE & CO (US) 2001-07-18 EP claimed
CN-1201454-A Meta-guanidino, ureido, thioureido or azacyclic aminobenzoic acid derivatives as integrin antagonists SEARLE & CO (US) 1998-12-09 CN claimed
US-6831199-B1 In order to avoid bleeding side-effects when treating the conditions associated with integrin alpha v beta 3, it is beneficial to have compounds which are selective antagonists for alpha v beta 3 versus alpha IIb beta 3 G. D. SEARLE & CO. 2004-12-14 US disclosed
EP-0850221-B1 META-GUANIDINE, UREA, THIOUREA OR AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS SEARLE & CO (US) 2001-07-18 EP disclosed
US-6028223-A AN INTEGRIN ANTAGONISTS TREATING BONE DISORDER, PERIODONTAL DISEASE, OSTEOPOROSIS, HUMORAL HYPERCALCEMIA OF MALIGNANCY, PAGET'S DISEASE, TUMOR ANGIOGENESIS, DIABETIC RETINOPATHY, ARTHRITIS, SMOOTH MUSCLE CELL MIGRATION AND RESTENOSIS G. D. SEARLE & CO. (US) 2000-02-22 US disclosed